Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Stockholders' Equity (Deficit)

v3.22.4
Consolidated Statement of Stockholders' Equity (Deficit) - USD ($)
Total
Common Stock
Series A Preferred Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Common stock, beginning balance (in shares) at Dec. 31, 2019   67,105,000        
Beginning balance at Dec. 31, 2019 $ (34,913,110) $ 67,105 $ 0 $ 143,826,315 $ (178,806,530) $ 0
Preferred stock, beginning balance (in shares) at Dec. 31, 2019     0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options and warrants exercised and vesting of restricted shares (in shares)   33,932,827        
Stock options and warrants exercised, and vesting of restricted shares 82,093,632 $ 33,933   82,059,699    
Common stock issued for preferred stock dividend (in shares)   920,901        
Common stock issued for preferred stock dividends 1,491,860 $ 922   1,490,938    
Conversion of convertible notes (in shares)   19,605,013        
Conversion of convertible notes 270,794,684 $ 19,605   270,775,079    
Common stock issued for interest on convertible notes (in shares)   358,791        
Common stock issued for interest on convertible notes 1,939,964 $ 358   1,939,606    
Stock-based compensation 4,020,805     4,020,805    
Net (loss) income 69,776,499       69,776,499  
Common stock, ending balance (in shares) at Dec. 31, 2020   121,922,532        
Ending balance at Dec. 31, 2020 395,204,334 $ 121,923 $ 0 504,112,442 (109,030,031) 0
Preferred stock, ending balance (in shares) at Dec. 31, 2020     0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options and warrants exercised and vesting of restricted shares (in shares) [1]   2,281,393        
Stock options and warrants exercised, and vesting of restricted shares [1] (4,429,163) $ 2,281   (4,431,444)    
Conversion of convertible notes (in shares)   27,711,530        
Conversion of convertible notes 181,721,535 $ 27,712   181,693,823    
Stock-based compensation 4,943,380     4,943,380    
Net (loss) income (401,344,813)       (401,344,813)  
Other comprehensive (loss) income $ (1,402,500)         (1,402,500)
Common stock, ending balance (in shares) at Dec. 31, 2021 151,915,455 151,915,455        
Ending balance at Dec. 31, 2021 $ 174,692,773 $ 151,916 $ 0 686,318,201 (510,374,844) (1,402,500)
Preferred stock, ending balance (in shares) at Dec. 31, 2021 0   0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued under ATM (in shares)   4,889,986        
Common stock issued under ATM $ 12,884,243 $ 4,890   12,879,353    
Common stock issued for service providers (in shares)   244,035        
Common stock issued for service providers 599,982 $ 244   599,738    
Stock options and warrants exercised and vesting of restricted shares (in shares) [1]   722,213        
Stock options and warrants exercised, and vesting of restricted shares [1] (559,637) $ 721   (560,358)    
Conversion of convertible notes (in shares)   7,833,666        
Conversion of convertible notes 25,381,077 $ 7,834   25,373,243    
Stock-based compensation 11,460,211     11,460,211    
Net (loss) income (117,274,218)       (117,274,218)  
Other comprehensive (loss) income $ 1,402,500         1,402,500
Common stock, ending balance (in shares) at Dec. 31, 2022 165,605,355 165,605,355        
Ending balance at Dec. 31, 2022 $ 108,586,931 $ 165,605 $ 0 $ 736,070,388 $ (627,649,062) $ 0
Preferred stock, ending balance (in shares) at Dec. 31, 2022 0   0      
[1] Net of tax payments related to shares withheld for option exercises and vested stock.